About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

17

Jan

2018

CVS Caremark - Amendments to 2018 Caremark Provider Manual

Effective January 1, 2018

A. Massachusetts Addendum to Caremark Provider Agreement

17

Jan

2018

MagellanRx - Pre-Exposure Prophylaxis Assistance Program

Beginning early 2018, the CDPH/OA will be utilizing the pharmacy benefits manager Magellan Rx Management for the PrEP-AP.

17

Jan

2018

Express Scripts - Johnson Controls International selected Express Scripts as new PBM

Effective January 1, 2018

Johnson Controls International selected Express Scripts as its new PBM. Effective Jan. 1, Johnson Controls members have new combination medical and prescription ID cards from BlueCross Blue Shield of Illinois.

17

Jan

2018

OptumRx - Workers Compensation Texas Quarterly Client Listing

In accordance with Texas Labor Code §408.0281, OptumRx on behalf of itself and each of its affiliate(s) that provides pharmacy benefit management services (including but not limited to Catamaran LLC, Healthcare Solutions, Inc.

16

Jan

2018

Blue Cross and Blue Shield of Alabama: TEMPORARILY LIFTS EDIT ON COMPOUNDED TAMIFLU

Blue Cross and Blue Shield of Alabama: TEMPORARILY LIFTS EDIT ON COMPOUNDED TAMIFLU

APNS just received notice from Blue Cross and Blue Shield of Alabama (BCBSAL), they are lifting their edit for compounded Tamiflu due to a shortage on the suspension. The edit is subject to change based on availability. For any questions you may have, please contact Prime Therapeutics directly at 1-800-216-9920.


First 216217218219 Last